Abrogating Merlin from MCF10AT and MCF7 breast cancer cells caused a significant (p < 0.05) upregulation of TOPFlash activity indicating activation of β-catenin–mediated transcription (Figure 2A). The gene discussed is NF2; the disease is breast carcinoma.